4.4200 +0.88 (24.86%)
Before hours: 8:30AM EDT
|Bid||3.4300 x 2900|
|Ask||3.5300 x 800|
|Day's Range||3.3300 - 3.8100|
|52 Week Range||2.5200 - 54.6000|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 12, 2020 - Aug 17, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.00|
PRINCETON, NJ / ACCESSWIRE / August 4, 2020 / Sonnet BioTherapeutics Holdings, Inc.
* Data provide proof-of-concept for advancing SON-2014, a bispecific combination of GMcSF and IL-18 * The company will further explore the utility of a bispecific combination of GMcSF and IL-12PRINCETON, NJ / ACCESSWIRE / July 20, 2020 / Sonnet BioTherapeutics Holdings, Inc.
PRINCETON, NJ / ACCESSWIRE / July 15, 2020 / Sonnet BioTherapeutics, Inc., a company developing innovative targeted biologic drugs with enhanced single or bispecific mechanisms, announced today that Pankaj ...